Laxans

Sodium Picosulfate, the active ingredient in Laxans, is a stimulant laxative presented as an oral formulation for oral use. It promotes bowel movements in patients with constipation and is employed for bowel cleansing prior to diagnostic procedures such as colonoscopy.

GNH USA supplies Laxans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All batches are manufactured under stringent GMP standards and undergo comprehensive quality testing before release, complying with European Union pharmacopeial specifications for export to multiple regulatory markets.

Sodium Picosulfate, a stimulant laxative, is indicated for conditions involving reduced bowel motility. - Constipation: facilitates bowel evacuation and relieves symptoms of infrequent or difficult stool passage. - Bowel cleansing before diagnostic procedures: prepares the colon by inducing evacuation for colonoscopy or radiographic studies. - Pre‑operative bowel preparation: clears the intestinal tract prior to surgical interventions requiring a clean colon.

Sodium picosulfate may cause a range of adverse reactions, most of which are related to its laxative action.

Common Side Effects: - Abdominal cramps: mild to moderate cramping during bowel evacuation. - Diarrhea: loose stools occurring shortly after dosing. - Nausea: feeling of queasiness without vomiting. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss requiring medical attention. - Electrolyte imbalance: abnormal sodium or potassium levels that may cause cardiac issues. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Colitis: inflammation of the colon presenting with severe pain and bleeding.

Before prescribing sodium picosulfate, clinicians should consider several safety measures. - Assess bowel function: confirm presence of constipation and rule out obstruction before use. - Use under medical supervision: dosage and duration should be determined by a healthcare professional. - Avoid in intestinal blockage: contraindicated in patients with known bowel obstruction or perforation. - Monitor fluid and electrolytes: ensure adequate hydration and watch for electrolyte disturbances during treatment. - Do not combine with other laxatives: concurrent use may increase risk of severe diarrhea unless advised. - Store at ambient temperature: keep in the original packaging, protect from moisture and heat.

Sodium picosulfate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Opioid analgesics: may counteract the laxative effect by reducing gastrointestinal motility. - Anticholinergic agents: can diminish the stimulant action on the colon. - Certain diuretics: increase risk of electrolyte imbalance when combined with the laxative.

Moderate Interactions (Monitor Closely): - Antacids: may alter the intestinal environment and affect drug conversion. - NSAIDs: concurrent use may increase gastrointestinal irritation. - Magnesium‑containing supplements: can potentiate the laxative effect and lead to excess fluid loss.